This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Response assessment
Depth of response
*Reduction from pretreatment baseline.
CR, complete response; CT, computed tomography; IF, immunofixation; IHC, immunohistochemistry; MM, multiple myeloma; MR, minimal response; MRD, minimal residual response; NGF, next-generation flow; NGS, next-generation sequencing; PET, positron emission tomography; PR, partial response; VGPR, very good partial response; sCR, stringent complete response.
Kumar S, et al. Lancet Oncol. 2016;17:e328-e346.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.